/guid/9202a8c04000641f8000000005adf7d1 rename
Summary
Lucatumumab is a human monoclonal antibody being investigated for the treatment of various types of...
Content
Lucatumumab is a human monoclonal antibody being investigated for the treatment of various types of cancer like multiple myeloma, non-Hodgkin's or Hodgkin's lymphoma.
This drug was developed by Novartis Pharmaceuticals Corp.
Created by:
Freebase Data Team
Aug 16, 2007
Last edited by:
Freebase Data Team
Aug 16, 2007
Recent Discussions about None
There is no discussion about this document.
Start the Discussion »